Compliance Implementation Services

CIS's Krzeminski identifies potential risks of not forming and implementing an auditing and monitoring plan

Diane Dellaratta, Billy Grimme, and Karen Chaney will assume clinical consultant positions with varying degrees of responsibility within CIS’ clinical team headed by Annette Horner, senior director of global clinical compliance.

CIS has announced that Kathy Castoro will assume the position of Senior Manager of Pharmaceutical Consulting. Kathy brings two decades of government pricing compliance and contracting experience from top pharma companies.

CIS is pleased to announce that Erica L. Brooks has completed the requirements to be named by the Certification Board of the American Society for Quality as an ASQ-Certified Quality Auditor.

Tim Krzeminski has joined CIS as director of its pharmaceutical consulting group. He will assist business development in promoting the depth of expertise of CIS’ audit services.

CIS, a pharmaceutical compliance consulting firm, announced today that it will offer a free supplier management program assessment to pharmaceutical manufacturers in an effort to assist them with their 2010-2011 supplier audits.

CIS CFO and VP of Operations Jim Collins recently participated in the 5th annual Robert Half Executive Roundtable discussion to address increased Chief Financial Officer-Chief Information Officer collaboration

CIS, a pharmaceutical compliance consulting firm, announced today that Judy Fox, CIS Director for U.S. Global Compliance, has been re-elected to a three-year term on the PDMA Alliance Inc. Board of Directors.

CIS announced the publication of its white paper on compliance-focused approaches to establishing an efficient, effective and sustainable Corrective Action/Preventative Action (CAPA) system for pharmaceutical manufacturers.

Compliance Implementation Services (CIS) announced today that it has been named to Inc. Magazine’s fourth annual Top 5000 list of fastest-growing privately held companies in the United States.